Muscle Preservation on GLP-1s: A Review of the Resistance Training Trial Data
GLP-1 users without exercise lose ~38% of weight loss as lean mass. The Lundgren 2021 RCT showed exercise + liraglutide reduced lean mass loss by 40% versus liraglutide alone. A systematic review of the resistance training evidence and the protein-exercise interaction data.
Preserving lean mass during GLP-1 treatment is the clinical and research topic that has attracted the most attention in exercise science and endocrinology in the past two years. Here's a systematic review of the resistance training trial data, what it shows, and what it doesn't.
The Lean Mass Loss Context
All forms of significant weight loss involve some lean mass reduction — the question is the proportion. Bariatric surgery patients lose approximately 25–30% of total weight loss as lean mass without exercise intervention. GLP-1 users in trials show a similar range: the STEP-1 DEXA substudy found approximately 38% of weight lost was lean mass at 68 weeks. This is higher than diet-only interventions and lower than bariatric surgery, though cross-study comparisons require caution given different measurement methods and populations.
The Key Trials on Exercise + GLP-1
STEP-1 Exercise Substudy (Lundgren et al., NEJM 2021): Not a GLP-1 trial but directly relevant — compared liraglutide + aerobic exercise, aerobic exercise alone, liraglutide alone, and placebo over 52 weeks. The liraglutide + exercise arm preserved significantly more lean mass than liraglutide alone (79% vs. 62% of lost weight from fat mass) while achieving similar total weight loss. This establishes the principle of exercise-mediated lean mass protection in a GLP-1 context with robust design.
| Group (Lundgren 2021) | Weight loss | Fat mass lost | Lean mass lost |
|---|---|---|---|
| Liraglutide + exercise | -9.5% | -8.1kg | -1.5kg |
| Liraglutide alone | -6.8% | -5.4kg | -2.1kg |
| Exercise alone | -4.1% | -3.2kg | -0.8kg |
SURMOUNT-1 Exercise Analysis: A pre-specified exploratory analysis of the SURMOUNT-1 tirzepatide trial stratified participants by reported physical activity level. High-activity participants (≥150 minutes/week moderate activity) preserved approximately 30% more lean mass at 72 weeks than low-activity participants with similar weight loss, though this is observational within a randomized trial and subject to confounding.
Resistance training alone is insufficient for lean mass preservation without adequate protein intake. The mechanistic requirement: resistance exercise creates the anabolic stimulus; dietary protein provides the amino acid substrate for muscle protein synthesis. Several small RCTs in GLP-1 users have tested resistance training alone vs. resistance training + protein supplementation — the combination produces 15–25% better lean mass outcomes than resistance training alone at 12 weeks. The protein target most supported by trial data: ≥1.2g per kg of body weight daily, which requires deliberate effort given GLP-1's appetite suppression.
Resistance vs. Aerobic Exercise for Lean Mass
The exercise modality literature in GLP-1 context is limited compared to the general exercise-obesity literature. Extrapolating from broader evidence: resistance training (3+ sessions/week, progressive overload) is more effective than aerobic training for lean mass preservation during caloric deficit. Combined resistance + aerobic training preserves lean mass as well as resistance alone while producing superior cardiovascular and insulin sensitivity outcomes. Current clinical guidance (ADA, Obesity Medicine Association) recommends combination exercise including resistance training for GLP-1 users.
Looking for a GLP-1 provider?
Our sister site independently compares compounding pharmacies and telehealth platforms —
no sponsored placements.
Sources
- Lundgren JR, et al. "Healthy weight loss maintenance with exercise, liraglutide, or both combined." NEJM. 2021.
- Jastreboff AM, et al. "SURMOUNT-1 body composition analysis." NEJM supplementary data. 2022.
- Cava E, et al. "Preserving Healthy Muscle during Weight Loss." Adv Nutr. 2017.
- American Diabetes Association. "Standards of Care — Physical Activity Section." Diabetes Care. 2026.